Image-guided Therapy Systems Market Report by Product, Application, End Use, Countries and Companies Analysis 2026-2034

Image-guided Therapy Systems Market Size and Forecast

Image-guided Therapy Systems Market is projected to grow from US$ 5.26 billion in 2025 to US$ 8.92 billion by 2034, registering a CAGR of 6.05% during 2026–2034. Market expansion is expected to be driven by continuous technological advancements, growing demand for greater procedural accuracy, and the increasing adoption of minimally invasive treatment approaches. Furthermore, rising healthcare investments in advanced imaging technologies, modern medical infrastructure, and precision-focused treatment solutions are supporting the integration of image-guided systems across hospitals and specialized healthcare facilities.

What are Image-Guided Therapy Systems and its Uses & Popularity Worldwide

Image-guided therapy systems are advanced medical technologies that combine real-time imaging, navigation, and treatment-delivery capabilities to help physicians visualize anatomy and accurately guide minimally invasive procedures. These systems incorporate technologies such as X-ray/fluoroscopy, ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), endoscopy, and other imaging modalities. They are widely used in cardiac surgery, oncology, neurosurgery, orthopedic surgery, gastroenterology, urology, and interventional radiology. Applications include catheter and stent placement, tumor treatment, biopsies, ablation procedures, vascular interventions, and surgical navigation. The FDA notes that image-guided techniques are commonly used for procedures such as placing catheters and stents and removing blood clots or other blockages. Their popularity is increasing because they can improve anatomical visualization and procedural precision while supporting minimally invasive approaches. Increasing chronic disease prevalence, technological innovation, aging populations, and investments in advanced healthcare infrastructure are supporting adoption worldwide.

Growth Driver in the Market

Increasing Need for Precise Diagnosis and Targeted Treatment

The growing global burden of chronic diseases is a major driver of demand for image-guided therapy systems because many complex conditions require accurate visualization, localization, and minimally invasive intervention. According to the World Health Organization, noncommunicable diseases caused at least 43 million deaths in 2021, equivalent to approximately 75% of non-pandemic-related deaths globally. Cardiovascular diseases accounted for at least 19 million deaths, while cancers caused approximately 10 million deaths in the same year. These conditions frequently require advanced interventions in which real-time imaging can help physicians navigate instruments and target affected tissues. Image guidance is particularly valuable in oncology, cardiology, neurosurgery, and vascular procedures where accurate targeting can influence treatment delivery. As disease prevalence increases and procedures become more sophisticated, healthcare providers are increasingly investing in imaging and navigation systems capable of supporting precise, minimally invasive treatment.

Demand for Greater Precision and Shorter Recovery

The increasing adoption of minimally invasive procedures is accelerating demand for image-guided therapy systems because physicians require high-quality, real-time visualization when operating through small incisions or using catheter-based techniques. Image guidance allows clinicians to visualize anatomy and track instruments during interventions, supporting procedures that can reduce tissue trauma compared with conventional open surgery. X-ray and fluoroscopy systems alone accounted for more than 30% of the image-guided therapy systems market in 2024, according to Global Market Insights, reflecting their extensive application in cardiology, orthopedics, and interventional radiology. The growing preference for less invasive treatment, reduced hospital stays, faster recovery, and improved procedural visualization is encouraging hospitals and ambulatory surgical centers to invest in image-guided technologies. This trend is expected to remain an important market growth catalyst worldwide.

AI, Real-Time Imaging, and Hybrid Operating Rooms Enhance Adoption

Rapid technological innovation is transforming image-guided therapy systems and expanding their applications across multiple medical specialties. Modern platforms increasingly integrate artificial intelligence, 3D and 4D imaging, electromagnetic navigation, image fusion, robotics, and advanced software to improve anatomical visualization and procedural guidance. At the same time, healthcare providers are investing in hybrid operating rooms that combine advanced imaging systems with surgical infrastructure. These facilities enable clinicians to perform complex interventions while accessing real-time anatomical information during procedures. Grand View Research estimates that North America accounted for more than 33% of global market revenue in 2024, reflecting its advanced healthcare infrastructure and rapid adoption of medical technologies. Increasing healthcare expenditure, modernization of hospitals, expansion of ambulatory surgical centers, and development of AI-enabled navigation systems are therefore creating opportunities for manufacturers and supporting wider adoption of image-guided therapy technologies.

Challenges in the Market

Expensive Systems Can Limit Adoption in Resource-Constrained Settings

The high acquisition and installation costs associated with image-guided therapy systems represent a significant challenge, particularly for smaller hospitals, ambulatory facilities, and healthcare providers in emerging markets. Advanced systems may involve expensive imaging hardware, navigation platforms, software, specialized operating-room infrastructure, and ongoing maintenance. Hybrid operating rooms can require substantial capital investment because healthcare facilities must integrate imaging equipment with surgical tables, navigation systems, displays, networking infrastructure, and specialized technical support. These costs can make adoption difficult for hospitals operating under constrained capital budgets. The challenge is particularly relevant in low- and middle-income countries, where WHO reports that 82% of premature deaths from noncommunicable diseases occur, despite many healthcare systems having fewer resources available for advanced medical technologies. In addition to initial procurement costs, healthcare providers must consider software upgrades, equipment servicing, staff training, and replacement components. Consequently, hospitals may delay technology upgrades or prioritize systems with broader clinical utilization. Greater financing availability, public healthcare investment, leasing models, and cost-effective technologies could help expand access to image-guided therapy systems.

Specialized Expertise and Safety Protocols Remain Essential

The operation of sophisticated image-guided therapy systems requires trained physicians, radiologists, surgeons, technicians, nurses, and other specialized personnel. Advanced systems may combine multiple imaging modalities, navigation technologies, software platforms, and interventional devices, making staff training essential for safe and effective use. Workforce limitations can therefore slow adoption, particularly in healthcare facilities without specialized interventional teams. Radiation exposure is another consideration for procedures involving X-ray and fluoroscopy. The U.S. Food and Drug Administration emphasizes the importance of managing unnecessary radiation exposure from medical imaging while recognizing the clinical value of imaging for diagnosis, treatment planning, and image-guided procedures. Healthcare providers consequently need appropriate radiation-protection protocols, staff training, equipment maintenance, and dose-monitoring procedures. In addition, interoperability between imaging equipment, navigation platforms, hospital information systems, and surgical devices can create technical complexity. Cybersecurity and software maintenance requirements are also becoming increasingly relevant as systems become connected and data-driven. Addressing training, workflow integration, radiation safety, and technology-management challenges will be important for sustainable global adoption.

Image-guided Therapy Systems Launches Worldwide

1. Philips Azurion Neuro Biplane – Europe, February 2024
   Philips launched the Azurion neuro biplane image-guided therapy system at ECR 2024. The system provides enhanced 2D and 3D imaging, flexible X-ray detector positioning, and dedicated neurovascular tools for stroke and other neurovascular procedures.
2. Philips Zenition 90 Motorized – Worldwide, February 2024
   Philips introduced the Zenition 90 Motorized, a high-power mobile C-arm designed for complex vascular procedures, cardiac interventions, pain management, and urology. The system provides 25 kW of power and automated workflow features.
3. GE HealthCare Allia IGS Pulse – United States, October 2023
   GE HealthCare’s Allia IGS Pulse received FDA 510(k) clearance. The system incorporates a redesigned imaging chain intended to provide high-quality imaging at optimized radiation doses for complex cardiology interventions.
4. Stryker Q Guidance System – United States, July 2023
   Stryker commercially launched the Q Guidance System with Cranial Guidance Software, providing image-based planning and intraoperative guidance for instrument positioning and anatomical identification during cranial procedures.
5. GE HealthCare CleaRecon DL – Worldwide, May 2025
   GE HealthCare launched CleaRecon DL, an AI-powered technology designed to improve cone-beam CT image quality. The deep-learning solution helps reduce streak artifacts and supports image-guided procedures involving the liver, prostate, neurovascular system, and endovascular aortic repair.
6. Philips CT-guided PCI Integration – Worldwide, October 2025
   Philips introduced an integration that automatically synchronizes pre-operative CT data with C-arm movement on its Azurion platform. The technology is designed to provide additional anatomical information during percutaneous coronary intervention and represents a step toward CT-guided PCI.
7. Siemens Healthineers OPTIQ AI – Worldwide, November 2025
   Siemens Healthineers introduced OPTIQ AI, an AI-powered imaging chain designed to improve low-dose image quality for image-guided procedures. It uses AI-based live image denoising and is available across platforms including ARTIS genio and ARTIS icono systems.
8. GE HealthCare Allia Moveo – Worldwide, December 2025
   GE HealthCare unveiled Allia Moveo, an image-guidance solution featuring a compact, cable-free C-arm designed to improve mobility and access within interventional suites. It also incorporates lateral wide-bore cone-beam CT capabilities.
9. Philips LumiGuide 3D Device Guidance – Europe & United States, December 2025
   Philips expanded commercial availability of LumiGuide 3D Device Guidance, an AI-enabled, light-based 3D navigation technology. It provides real-time visualization of endovascular devices using light rather than X-ray and integrates with the Azurion platform.
10. Brainlab Spine Mixed Reality Navigation – United States, September 2025
    Brainlab announced FDA 510(k) clearance and the U.S. launch of its Spine Mixed Reality Navigation system. The technology combines optical navigation with mixed reality to assist surgeons with pedicle screw placement during minimally invasive spine procedures.

United States Advanced Healthcare Infrastructure and Aging Population Support Adoption

United States represents a highly developed market for image-guided therapy systems, supported by advanced medical infrastructure, strong R&D capabilities, and increasing demand for precision-based minimally invasive procedures. These technologies are increasingly used in cardiology, oncology, neurology, orthopedics, and interventional radiology, where real-time visualization can improve procedural guidance. The aging population is an important demand factor. According to the U.S. Census Bureau, the number of Americans aged 65 and older is projected to reach approximately 80 million by 2040, compared with 56 million in 2020, increasing demand for healthcare services associated with age-related diseases. The growing burden of chronic conditions such as cardiovascular disease, diabetes, and arthritis is also supporting procedural demand. Hospitals are investing in digital operating rooms, robotic-assisted surgery, advanced imaging, and integrated navigation platforms. Systems such as Innova IGS 520, Innova IGS 530, Optima IGS 320, and Optima IGS 330 have supported clinical applications. GE HealthCare, Brainlab, and Medtronic are among the notable industry participants.

United Kingdom NHS Modernization and Minimally Invasive Care Drive Market Development

The United Kingdom Image-guided Therapy Systems Market is benefiting from healthcare modernization, increasing adoption of minimally invasive procedures, and continued investment in advanced diagnostic and therapeutic technologies. The National Health Service (NHS) provides a substantial clinical environment for image-guided interventions across cardiology, oncology, neurology, vascular surgery, and orthopedics. According to the Office for National Statistics, people aged 65 years and over accounted for approximately 19% of the UK population in 2023, compared with around 16% in 2003, highlighting the country’s steadily aging demographic. Older populations generally require greater volumes of diagnostic and interventional healthcare services. The NHS is also increasing its focus on reducing waiting times, improving treatment efficiency, and adopting technologies that can support shorter hospital stays. Image-guided systems complement these objectives by enabling precise catheter-based and minimally invasive interventions. Collaboration among universities, NHS hospitals, medical-technology companies, and research institutions is supporting technological development. Continued digitalization, infrastructure upgrades, and demand for precision treatment are expected to sustain market expansion across the United Kingdom.

China Healthcare Investment and Medical Technology Localization Accelerate Adoption

China is emerging as an important market for image-guided therapy systems as healthcare infrastructure expands and hospitals increasingly adopt sophisticated medical technologies. Government investment in healthcare modernization, technological innovation, and domestic medical-device manufacturing is supporting the development of advanced imaging and therapeutic capabilities. China’s large patient population provides a substantial underlying demand base. According to the National Bureau of Statistics of China, the population aged 60 years and above reached approximately 310.3 million in 2024, representing 22.0% of the country’s population, while people aged 65 and above accounted for 15.6%. Population aging is increasing demand for treatment of cardiovascular diseases, cancer, musculoskeletal disorders, and other conditions requiring advanced interventions. Chinese hospitals are increasingly integrating 3D imaging, navigation technologies, robotic-assisted procedures, and interventional imaging into clinical workflows. Domestic manufacturers are also strengthening research and development capabilities and expanding their medical-device portfolios. Rising healthcare expenditure, greater awareness of minimally invasive procedures, hospital modernization, and efforts to improve access to specialized care are expected to support continued growth of China’s image-guided therapy systems market.

Saudi Arabia Vision 2030 and Specialized Healthcare Investment Support Growth

Saudi Arabia’s Image-guided Therapy Systems Market is expanding as the Kingdom modernizes healthcare infrastructure and increases access to specialized medical services. Image-guided technologies are increasingly relevant to cardiology, oncology, neurology, vascular interventions, and orthopedic procedures, particularly as hospitals seek greater procedural precision and minimally invasive treatment options. Saudi Arabia’s Vision 2030 healthcare transformation agenda emphasizes improved healthcare quality, digitalization, medical infrastructure, and greater access to advanced services. According to the World Bank, Saudi Arabia’s population aged 65 years and above was approximately 3.3% of the total population in 2023, while the country’s overall population continues to expand and healthcare demand is increasing. The high burden of conditions such as diabetes and cardiovascular disease is creating demand for advanced diagnostic and interventional procedures. Investments in tertiary hospitals, specialized medical centers, digital operating rooms, and physician training are supporting adoption. The introduction of advanced imaging, navigation, and robotic technologies is further improving procedural capabilities. Continued healthcare transformation and investment in specialized facilities are expected to create opportunities for image-guided therapy system manufacturers and service providers in Saudi Arabia.

Recent Developments in Image-guided Therapy Systems Market

• IntraSight Plus, an intuitive interventional guiding platform approved for clinical use in the United States and Europe after receiving FDA 510(k) approval and the CE mark, was introduced by Royal Philips in March 2026. To improve productivity, simplicity, and accuracy on a single platform, the revamped system incorporates cutting-edge diagnostic and treatment-planning technologies.
• The innovative Azurion image-guided therapy device from Philips India was added to intervention lists in a number of specialties in November 2024. The system's improved imaging capabilities and optimized processes are intended to improve cardiovascular and neurovascular disease treatment outcomes. Features like quick switching between 2D and 3D imaging, extensive table-side control, and AI-powered remote monitoring for proactive servicing are all included in the Azurion. The technology, which is on display at the Philips Innovation Campus in Bengaluru, seeks to improve patient care, efficiency, and accuracy while cutting expenses.

Image-guided Therapy Systems Market Segmentation

Product

• Endoscope
• Magnetic Resonance Imaging
• Computed Tomography Scanners
• Ultrasound Systems
• X-Rat Fluoroscopy
• Single Photon Emission Computed Tomography
• Positron Emission Tomography

Application

• Cardiac Surgery
• Neurosurgery
• Orthopedic Surgery
• Urology
• Gastroenterology
• Oncology Surgery
• Others

End Use

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Research & Academic Institutions

Countries

North America

• United States
• Canada

Europe

• France
• Germany
• Italy
• Spain
• United Kingdom
• Belgium
• Netherlands
• Turkey

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Thailand
• Malaysia
• Indonesia
• New Zealand

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• South Africa
• Saudi Arabia
• United Arab Emirates

All the Key players have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Key Players Analysis

• Siemens Healthineers
• Koninklijke Philips
• General Electric Company
• Brainlab
• Medtronic Plc
• Olympus Corporation
• KARL STORZ SE & Co. KG
• Stryker Corporation

Report Details: